Insider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells 6,687 Shares of Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Patrick Miles sold 6,687 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $12.00, for a total transaction of $80,244.00. Following the transaction, the chief executive officer now owns 5,501,715 shares in the company, valued at $66,020,580. This represents a 0.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Alphatec Stock Performance

NASDAQ ATEC opened at $11.01 on Friday. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21. The company has a market capitalization of $1.56 billion, a P/E ratio of -8.60 and a beta of 1.41. Alphatec Holdings, Inc. has a 12-month low of $4.88 and a 12-month high of $17.34. The firm has a 50-day moving average price of $9.92 and a two-hundred day moving average price of $8.10.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on ATEC shares. Barclays boosted their price objective on shares of Alphatec from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Wednesday. HC Wainwright reaffirmed a “buy” rating and set a $20.00 target price on shares of Alphatec in a report on Tuesday, January 14th. Finally, Needham & Company LLC lifted their target price on shares of Alphatec from $13.00 to $16.00 and gave the stock a “buy” rating in a report on Monday, January 13th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $17.56.

Institutional Trading of Alphatec

A number of institutional investors have recently bought and sold shares of ATEC. R Squared Ltd bought a new stake in Alphatec in the 4th quarter valued at about $29,000. Nisa Investment Advisors LLC raised its position in shares of Alphatec by 973.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company’s stock valued at $43,000 after buying an additional 4,234 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of Alphatec in the 3rd quarter valued at approximately $69,000. Net Worth Advisory Group acquired a new position in shares of Alphatec in the 3rd quarter valued at approximately $76,000. Finally, Van ECK Associates Corp raised its position in shares of Alphatec by 57.0% in the 3rd quarter. Van ECK Associates Corp now owns 19,273 shares of the medical technology company’s stock valued at $99,000 after buying an additional 6,998 shares in the last quarter. Institutional investors own 66.35% of the company’s stock.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.